Name
osaühing Kuressaare Apteek
Registry code
10033199
VAT number
EE100553570
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
30.04.1996 (28)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
4773 - Dispensing chemist in specialised stores
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Maarja Tiitson 12.02.1990 (34) | 100% - 2 556.00 EUR | Board member | Direct ownership |
| 2019 30.10.2020 | 2020 07.07.2021 | 2021 28.08.2022 | 2022 29.06.2023 | |
|---|---|---|---|---|
| Total Revenue | 767 048 € | 1 528 492 € | 1 754 212 € | 1 838 014 € |
| Net profit (loss) for the period | 13 308 € | 38 139 € | 29 647 € | 7 437 € |
| Profit Margin | 2% | 2% | 2% | 0% |
| Current Assets | 152 973 € | 275 791 € | 336 341 € | 399 743 € |
| Fixed Assets | 9 792 € | 16 892 € | 12 463 € | 8 138 € |
| Total Assets | 162 765 € | 292 683 € | 348 804 € | 407 881 € |
| Current Liabilities | 132 212 € | 239 991 € | 283 884 € | 345 524 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 30 553 € | 52 692 € | 64 920 € | 62 357 € |
| Employees | 3 | 8 | 8 | 8 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 503 770.93 € | 33 766.54 € | 28 972.37 € | 10 |
| 2023 Q4 | 532 410.79 € | 31 555.06 € | 25 074.83 € | 9 |
| 2023 Q3 | 516 634.91 € | 31 075.2 € | 23 226.43 € | 10 |
| 2023 Q2 | 474 460.99 € | 35 155.68 € | 29 959.73 € | 9 |
| 2023 Q1 | 439 041.07 € | 30 157.82 € | 24 101.31 € | 9 |
| 2022 Q4 | 485 195.8 € | 40 013.68 € | 28 336.02 € | 8 |
| 2022 Q3 | 493 584.9 € | 31 573.2 € | 25 898.92 € | 9 |
| 2022 Q2 | 447 176.91 € | 21 290.13 € | 17 404.08 € | 9 |
| 2022 Q1 | 430 430.33 € | 31 355.12 € | 25 058.71 € | 9 |
| 2021 Q4 | 471 624.03 € | 28 209.55 € | 21 075.35 € | 9 |
| 2021 Q3 | 472 343.95 € | 31 291.3 € | 21 825.6 € | 9 |
| 2021 Q2 | 416 264.58 € | 27 388.36 € | 23 121.26 € | 9 |
| 2021 Q1 | 407 604.84 € | 27 658.09 € | 22 495.23 € | 9 |
| 2020 Q4 | 448 179.64 € | 29 030.36 € | 23 142.53 € | 9 |
| 2020 Q3 | 425 218.06 € | 30 165.56 € | 22 144.42 € | 9 |
| 2020 Q2 | 364 083.49 € | 21 426.03 € | 16 086.08 € | 8 |
| 2020 Q1 | 239 683.11 € | 16 578.38 € | 14 158.99 € | 8 |
